A new statistical analysis of results from the National Lung Screening Trial (NLST) concludes that performing low-dose computerized tomography screening can be cost-effective compared to doing no screening ...
Nov 05, 2014
5 / 5 (1) | 0
Medicare costs analysis indicates need to decrease use of biopsies as diagnosis tool for lung cancer
Biopsies were found to be the most costly tool prescribed in lung cancer diagnosis, according to research presented today at the 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology. The Symposium is sponsored by ...
Oct 30, 2014
not rated yet | 0